High Throughput News and Research

RSS

Microbiome composition influences severity of Legionnaires' disease

Pneumonia is an infection of the lung alveoli caused by bacteria, viruses or fungi. It is one of the leading causes of morbidity and mortality worldwide, representing a clinical and economic burden and a global public health problem.

13 Sep 2023

INTEGRA’s pipetting solutions help Axis Healthcare to support patients in overcoming opioid addiction

Axis Healthcare, a family-run care facility in Oklahoma, has introduced VOYAGER adjustable tip spacing pipettes from INTEGRA Biosciences into its PCR laboratory workflows.

From INTEGRA Biosciences 13 Sep 2023

Scientists identify malaria-causing parasites resistant to both treatment and detection in Ethiopia

Scientists have detected new strains of malaria-causing parasites in Ethiopia that are both resistant to current treatments and escape detection by common diagnostic tests - a development that could increase cases and deaths from malaria and make eliminating the persistent disease an even greater challenge.

11 Sep 2023

Are airborne microplastics damaging your lungs? New study probes potential risks

Researchers review the presence and impact of airborne microplastics (AMPs) on human respiratory health in a new study published in the Science of the Total Environment. The study underscores the urgent need for more data on the toxicity of AMPs, which are prevalent in indoor environments and could pose serious health risks, especially to vulnerable populations like children and older adults.

7 Sep 2023

New device can help test treatments in patients with gliomas

The shape and size of a grain of rice, the new device can conduct dozens of experiments at once to study the effects of new treatments on some of the hardest-to-treat brain cancers.

7 Sep 2023

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.

6 Sep 2023

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

Researchers have developed a new blood test that measures mitochondrial DNA damage as a potential marker for Parkinson's disease (PD). The study shows the test could aid in diagnosing PD and assessing responses to LRRK2 kinase inhibitors, which may help in reducing mitochondrial damage in PD patients.

4 Sep 2023

Scientists convert former barn into cutting-edge animal behavior lab

Researchers from the Cluster of Excellence Centre for the Advanced Study of Collective Behaviour (CASCB) and the Max Planck Institute of Animal Behavior have converted a former barn into a cutting-edge technology lab for complex behavioral analysis

1 Sep 2023

Scale Biosciences Continues Commercial Expansion with Introduction of New and Differentiated Single Cell Methylation and Single Cell RNA Sequencing Solutions

Scale Biosciences, Inc. (ScaleBioTM), an innovator in single cell sequencing leveraging combinatorial indexing technologies, today announced an expansion of their product portfolio to enable a broader range of single cell omics experiments and unlock new translational research applications.

30 Aug 2023

Study discovers method to classify febrile illness with a single blood sample

Researchers trained machine learning (ML) models to analyze RNA molecular signatures in patients’ blood.

28 Aug 2023

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.

From Rapid Novor Inc 23 Aug 2023

The relationship between breast milk feeding and infants’ neurodevelopment via epigenetics

Researchers collated studies on the epigenetic advantages of breast milk feeding and neurodevelopment in infants.

22 Aug 2023

The growing role of AI in science and discovery

With the advent of ChatGPT4, the use of artificial intelligence in medicine has absorbed the public's attention, dominated news headlines, and sparked vigorous debates about the promise and peril of medical AI.

21 Aug 2023

Unleashing the Power of Microfluidic Picodroplets

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Richard Hammond, Chief Technical Officer at Sphere Bio, about their microfluidic picodroplet technology and more.

From Fluidic Sciences and Sphere Bio 21 Aug 2023

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Researchers report that convalescent plasma treatment is most effective in treating hospitalized COVID-19 patients.

17 Aug 2023

Researchers develop platform allowing mass-scale production of SARS-CoV-2 mRNA lipid nanoparticle vaccines

Researchers presented a scalable lipid nanoparticle production (SCALAR) platform to develop SARS-CoV-2 mRNA lipid nanoparticle vaccines.

15 Aug 2023

Genetic determinants of retinol circulation and their impact on health

The genetic architecture of circulating retinol.

15 Aug 2023

Epigenetic drug-sensitive biomarkers for cancer

Researchers perform an epigenome-wide multi-omic high-throughput screen to identify actionable epigenetic drug-sensitive biomarkers.

15 Aug 2023

Study explores the use of existing medicines to revolutionize cancer treatment

In a recent study published in the journal of Genes & Diseases, Research team led by Lu explores the potential for the use of FDA-approved hypertension and EMA-approved cough medicines to revolutionize cancer treatment.

10 Aug 2023

INTEGRA Biosciences’ pipettes help to sow the seeds of the future

California Seed and Plant (CSP) Labs, a leading private plant pathology and genetics testing laboratory in California, is using VIAFLO 96 and VIAFLO 384 handheld electronic pipettes from INTEGRA Biosciences to streamline its nucleic acid extraction and sample processing workflows.

From INTEGRA Biosciences 9 Aug 2023

High Throughput News and Research

Microbiome composition influences severity of Legionnaires' disease

INTEGRA’s pipetting solutions help Axis Healthcare to support patients in overcoming opioid addiction

Scientists identify malaria-causing parasites resistant to both treatment and detection in Ethiopia

Are airborne microplastics damaging your lungs? New study probes potential risks

New device can help test treatments in patients with gliomas

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

Scientists convert former barn into cutting-edge animal behavior lab

Scale Biosciences Continues Commercial Expansion with Introduction of New and Differentiated Single Cell Methylation and Single Cell RNA Sequencing Solutions

Study discovers method to classify febrile illness with a single blood sample

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

The relationship between breast milk feeding and infants’ neurodevelopment via epigenetics

The growing role of AI in science and discovery

Unleashing the Power of Microfluidic Picodroplets

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Researchers develop platform allowing mass-scale production of SARS-CoV-2 mRNA lipid nanoparticle vaccines

Genetic determinants of retinol circulation and their impact on health

Epigenetic drug-sensitive biomarkers for cancer

Study explores the use of existing medicines to revolutionize cancer treatment

INTEGRA Biosciences’ pipettes help to sow the seeds of the future

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News